Statements (48)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Professor
|
| gptkbp:advocacy |
Public health policy
Mental health awareness Drug reform Evidence-based drug policy Research funding for drug studies |
| gptkbp:affiliation |
gptkb:Imperial_College_London
|
| gptkbp:award |
gptkb:Royal_Society_of_Medicine_Medal
|
| gptkbp:birth_place |
gptkb:United_Kingdom
|
| gptkbp:collaboration |
gptkb:Non-profit_organizations
Academic institutions Pharmaceutical companies Government health agencies International drug research organizations |
| gptkbp:contribution |
Drug classification system
|
| gptkbp:controversy |
Drug policy advocacy
|
| gptkbp:education |
gptkb:University_of_Cambridge
|
| gptkbp:field |
Neuroscience
Psychopharmacology |
| https://www.w3.org/2000/01/rdf-schema#label |
Professor David Nutt
|
| gptkbp:impact |
Mental health treatment approaches
Drug policy reform in the UK Public understanding of drug effects Scientific research on psychoactive substances |
| gptkbp:influenced |
Public policy on drug use
|
| gptkbp:influenced_by |
gptkb:John_C._Lilly
|
| gptkbp:known_for |
Psychoactive drugs research
|
| gptkbp:media_appearances |
gptkb:Sky_News
gptkb:The_Times gptkb:BBC gptkb:The_Guardian gptkb:Channel_4 |
| gptkbp:notable_work |
Drugs Without the Hot Air
|
| gptkbp:position |
Chair of Neuropsychopharmacology
|
| gptkbp:public_perception |
Psychedelics should be legalized for therapeutic use
Cannabis should be regulated like alcohol Current drug laws are ineffective MDMA has therapeutic potential Psychoactive substances should be studied scientifically |
| gptkbp:publication |
gptkb:BMJ
gptkb:The_Lancet Psychopharmacology Journal of Psychopharmacology Neuroscience & Biobehavioral Reviews |
| gptkbp:research_focus |
Effects of drugs on the brain
|
| gptkbp:website |
www.davidnutt.com
|
| gptkbp:bfsParent |
gptkb:Leeds_University
|
| gptkbp:bfsLayer |
5
|